Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron deficiency as an ignored cause of infertility
2019-002040-24Phase 4Terminated
- Sponsor
- Dextra Fertility Clinic
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric carboxymaltose in female infertility and iron deficiency anemia (IDA), sponsored by Dextra Fertility Clinic. Primary endpoint: Number of good quality blastocysts. Started Jan 2020; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
female infertilityiron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2019-002040-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002040-24.